Phillip Pang, Chief Medical Officer at Vir Biotechnology, Inc. (VIR), sold 5,604 shares at $25.29 ($142K) on 2023-02-17, disclosed to the SEC on 2023-02-21.
Open-market sale of $142k VIR by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $25.29 | 2,802 | $71K | 50.0% |
| 2 | $25.29 | 2,802 | $71K | 50.0% |
| Total | $25.29 avg | 5,604 | $142K | 100% |
| Filing → |
| VIR | SELL | 2023-06-08 | $130K | — | Filing → |
| VIR | SELL | 2023-02-28 | $238K | — | Filing → |
| VIR | SELL | 2023-02-24 | $149K | — | Filing → |